What's in Ferrer Internacional S.A.'s pipeline?

Ferrer Internacional S.A. has 10 drugs in our index: 5 marketed, 0 filed, 1 in Phase 3, 3 in Phase 2, 1 in Phase 1.

Which companies overlap with Ferrer Internacional S.A.'s portfolio?

Top competitors by shared drug class: AbbVie, Archigen Biotech Limited, BioLineRx, Ltd., Assistance Publique - Hôpitaux de Paris, AstraZeneca.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ferrer-internacional-s-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Ferrer Internacional S.A. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ferrer Internacional S.A. pipeline: 5 marketed, 0 filed, 1 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 1 Phase 3 3 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
retapamulin 1% ointment	retapamulin 1% ointment	marketed
torasemide-IR	torasemide-IR	marketed
Furosemide-IR	Furosemide-IR	marketed
Torasemide Prolonged Release	Torasemide Prolonged Release	marketed
torasemide-PR	torasemide-PR	marketed	Loop diuretic	Na-K-2Cl cotransporter (NKCC2)	Cardiovascular
ozenoxacin 1% cream	ozenoxacin 1% cream	phase 3	Quinolone antibiotic	DNA gyrase and topoisomerase IV	Dermatology

Therapeutic area mix

Cardiovascular · 1
Dermatology · 1
Immunology · 1
Infectious Diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 2 shared drug classes
Archigen Biotech Limited · 1 shared drug class
BioLineRx, Ltd. · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
AstraZeneca · 1 shared drug class
B&A Therapeutics · 1 shared drug class
Aspirus Heart and Vascular Institute-Research and Education · 1 shared drug class
Allergan · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ferrer Internacional S.A.:

Cite this brief

Drug Landscape (2026). Ferrer Internacional S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ferrer-internacional-s-a. Accessed 2026-06-10.